Chou Outlines Key Challenges in US Biosimilars Marketplace in STAT News


In a special commentary appearing in STAT News, Jacki Chou, Senior Director, Policy & Economics,  and her co-author discuss overcoming 5 critical challenges in the US biosimilars marketplace, offering some strategic policy recommendations for the consideration of key healthcare stakeholders.

To read the complete commentary, please click here.

Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.